MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 2, 2007; DOI: 10.1124/mol.107.038570


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.038570v1
73/2/292    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, Q.
Right arrow Articles by Schonbrunn, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, Q.
Right arrow Articles by Schonbrunn, A.


Received for publication May 30, 2007.
Revised November 1, 2007.
Accepted for publication November 2, 2007.

Distinct phosphorylation sites in the sst2 somatostatin receptor control internalization, desensitization, and arrestin binding

Qisheng Liu 1, Dian A. Dewi 1, Weiley S. Liu 1, Mark S. Bee 1, Agnes Schonbrunn 1*

1 University of Texas - Houston, School of Medicine

* Address correspondence to: E-mail: agnes.schonbrunn{at}uth.tmc.edu

Abstract

The sst2A receptor, a member of the G-protein coupled receptor superfamily, mediates many of the neuroendocrine and neuromodulatory actions of somatostatin and represents the primary target for somatostatin analogs used in cancer therapy and tumor localization. Agonist stimulation leads to the rapid phosphorylation, endocytosis and desensitization of the sst2A receptor, however little is known about the role of phosphorylation in sst2A regulation. Sst2A phosphorylation occurs on serine and threonine residues in the third intracellular loop and carboxy-terminus. Therefore, we generated mutant receptors in which serine (Ser-), threonine (Thr-) or both (Ser-/Thr-) residues in these regions were mutated to alanine. In contrast to the wild type receptor, SS14 treatment did not stimulate the phosphorylation of the Ser-/Thr- mutant and did not produce desensitization. Further, internalization of the Ser-/Thr- mutant occurred 5-times more slowly than with the wild type receptor. Mutating only the Ser residues did not inhibit either internalization or desensitization. In contrast, mutating only the Thr residues inhibited receptor endocytosis to the same extent as in the full mutant but did not affect receptor desensitization. In both the wild type and Ser- receptors, agonist binding produced a stable arrestin-receptor complex that was maintained during receptor trafficking whereas arrestin was not recruited to either the Thr- or the Ser-/Thr- receptors. These results demonstrate that agonist stimulated receptor phosphorylation is necessary for both desensitization and rapid internalization of the sst2A receptor. However, sst2A receptor internalization and uncoupling can occur independently, involve different receptor phosphorylation sites and exhibit different requirements for stable arrestin association.


Key words: Neuropeptides, Somatostatin, Gi family, Adenylyl cyclases, cAMP, Desensitization/uncoupling, GRKs, barrestins, Phosphorylation/Dephosphorylation, Immunocytochemistry, Mutagenesis/Chimeric approaches





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics